Silver Creek Pharmaceuticals, Inc. — Form D
Silver Creek Pharmaceuticals, Inc. of San Francisco, CA, a company, filed a Form D exempt-offering notice with the SEC on 2022-02-14. The offering totals $25.0M, of which $9.2M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2022-02-14
- Form: D
- Accession: 0001209191-22-009063
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $25.0M
- Amount sold: $9.2M
- Remaining: $15.8M
- Investors: 22
- Date of first sale: 2022-01-31
- Security types: equity, debt
- Revenue range: Decline to Disclose
- SEC file number: 021-433467
Issuer
- Name: Silver Creek Pharmaceuticals, Inc.
- CIK: 0001691988
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Address: 409 Illinois Street, San Francisco, CA, 94158
- Phone: 415-978-2178
Officers, directors & promoters (16)
| Name | Role | Location |
|---|
| Mark Agne | Director | San Francisco, CA |
| James D Marks | Director | San Francisco, CA |
| Thomas J Murtagh | Director | San Francisco, CA |
| Nick J Taylor | Director | San Francisco, CA |
| Timothy Throsby | Director | Rye, NY |
| Lakhmir D Chawla | Executive Officer | San Francisco, CA |
| Kris D Kuchenbecker | Executive Officer | San Francisco, CA |
| Timothy Throsby | Executive Officer | Rye, NY |
| James Marks | Director | Conshohocken, PA |
| Ross Breckenridge | Director | San Francisco, CA |
| Ross Breckenridge | Executive Officer | San Francisco, CA |
| Michael Fairbanks | Director | San Francisco, CA |
| Ulrik Nielsen | Director | WALTHAM, MA |
| Tom Murtagh | Director | San Francisco, CA |
| Birgit Schoeberl | Director | San Francisco, CA |
| Birgit Schoeberl | Executive Officer | San Francisco, CA |
Other filings by this issuer (1)
More